Speaker
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Akihiro Furukawa, Global Director, Research & Technology Search & Evaluation at Daiichi Sankyo, appears in the programmes of 2 conferences on kongre.net. Next: 8th CNS Drug Delivery Summit (Boston, United States of America, 1–3 Dec 2026).
1–3 Dec 2026Boston, United States of America
9–10 Sept 2026Boston, United States of America
President & Chief Executive Officer, ArmaGen & JCR Pharmaceuticals
Head of Device Clinical, Biogen
Director, Neuromuscular Research, Dyne Therapeutics
Executive Director, Drug Delivery & Devices DDCS, Eli Lilly
Head of IDU Device Development & Manufacturing, Biogen
Principal Engineer, Delivery, Device, and Connected Solutions (DDCS), Eli Lilly
Science Partner, Flagship Pioneering
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Chief Business Officer, Nurix Therapeutics, Inc.
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Synthis Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Akihiro Furukawa, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].